Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$1.45 USD
-0.03 (-2.03%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.44 -0.01 (-0.69%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Corvus Pharmaceuticals, Inc. [CRVS]
Reports for Purchase
Showing records 141 - 154 ( 154 total )
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology -ESMO 2018 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Q4 Financials; Second Adenosine Program CD73 Antibody Moves in to Clinic
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
SITC Update Highlights Durability in RCC, Potential Biomarker Utility
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Biotechnology - SITC Meeting Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Q3 Financials; CPI-444 Data To be Updated at SITC
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
HEALTHCARE - 2017 PacGrow Healthcare Conference: Day 2 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Unclassified
Initiating with an OUTPERFORM and $26 PT: Active Agents Antagonizing Adenosine
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R